Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,207.99 +35.84 (+0.44%) Bitcoin USD
59,317.14 +1,552.55 (+2.69%) CMC Crypto 200
1,285.81 +8.83 (+0.69%)
STRATA Skin Sciences, Inc. (SSKN)
After hours:
| Previous close | 0.4120 |
| Open | 0.4100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4000 - 0.4590 |
| 52-week range | 0.2600 - 1.1000 |
| Volume | |
| Avg. volume | 26,577 |
| Market cap | 14.024M |
| Beta (5Y monthly) | 1.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024
HORSHAM, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the placement of six XTRAC® devices with dermatology clinics in the first quarter of 2024 that are considered “comebacks.” Comebacks are excimer placements with dermatology clinics that were previously active in the Com
- GlobeNewswire
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 that will become effective at 11:59 p.m. Eastern Time on June 6, 2024. The Company’s common stock will begin t
- GlobeNewswire
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & C
